155 related articles for article (PubMed ID: 32512143)
1. Novel molecular signatures and potential therapeutics in renal cell carcinomas: Insights from a comparative analysis of subtypes.
Caliskan A; Andac AC; Arga KY
Genomics; 2020 Sep; 112(5):3166-3178. PubMed ID: 32512143
[TBL] [Abstract][Full Text] [Related]
2.
Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
[TBL] [Abstract][Full Text] [Related]
3. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract][Full Text] [Related]
4. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
[TBL] [Abstract][Full Text] [Related]
5. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.
Zhao Q; Caballero OL; Davis ID; Jonasch E; Tamboli P; Yung WK; Weinstein JN; ; Strausberg RL; Yao J
Clin Cancer Res; 2013 May; 19(9):2460-72. PubMed ID: 23444225
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression profiling of Xp11 renal cell carcinoma.
Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive proteogenomic characterization of rare kidney tumors.
Li GX; Chen L; Hsiao Y; Mannan R; Zhang Y; Luo J; Petralia F; Cho H; Hosseini N; Leprevost FDV; Calinawan A; Li Y; Anand S; Dagar A; Geffen Y; Kumar-Sinha C; Chugh S; Le A; Ponce S; Guo S; Zhang C; Schnaubelt M; Al Deen NN; Chen F; Caravan W; Houston A; Hopkins A; Newton CJ; Wang X; Polasky DA; Haynes S; Yu F; Jing X; Chen S; Robles AI; Mesri M; Thiagarajan M; An E; Getz GA; Linehan WM; Hostetter G; Jewell SD; Chan DW; Wang P; Omenn GS; Mehra R; Ricketts CJ; Ding L; Chinnaiyan AM; Cieslik MP; Dhanasekaran SM; Zhang H; Nesvizhskii AI;
Cell Rep Med; 2024 May; 5(5):101547. PubMed ID: 38703764
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a two-gene metabolic signature for survival prediction in patients with kidney renal clear cell carcinoma.
Guo X; Sun Z; Jiang S; Jin X; Wang H
Aging (Albany NY); 2021 Mar; 13(6):8276-8289. PubMed ID: 33686951
[TBL] [Abstract][Full Text] [Related]
9. Sequential reinforcement active feature learning for gene signature identification in renal cell carcinoma.
Huang M; Ye X; Imakura A; Sakurai T
J Biomed Inform; 2022 Apr; 128():104049. PubMed ID: 35283266
[TBL] [Abstract][Full Text] [Related]
10. Panels of mRNAs and miRNAs for decoding molecular mechanisms of Renal Cell Carcinoma (RCC) subtypes utilizing Artificial Intelligence approaches.
Hosseiniyan Khatibi SM; Ardalan M; Teshnehlab M; Vahed SZ; Pirmoradi S
Sci Rep; 2022 Sep; 12(1):16393. PubMed ID: 36180558
[TBL] [Abstract][Full Text] [Related]
11. Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis.
Yu B; Zhang J; Sun Z; Cao P; Zheng X; Gao Z; Cao H; Zhang F; Wang W
Medicine (Baltimore); 2021 Jan; 100(1):e24257. PubMed ID: 33429832
[TBL] [Abstract][Full Text] [Related]
12. Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma?
Seliger B; Jasinski S; Dressler SP; Marincola FM; Recktenwald CV; Wang E; Lichtenfels R
J Proteome Res; 2011 Jan; 10(1):191-9. PubMed ID: 21142213
[TBL] [Abstract][Full Text] [Related]
13. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
Xing Q; Ji C; Zhu B; Cong R; Wang Y
Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
[TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
[TBL] [Abstract][Full Text] [Related]
16. Expression and Prognostic Significance of Cadherin 4 (CDH4) in Renal Cell Carcinoma.
Zhou X; Huang H; Cui W; Wang Y; Luo W; Matskova L; Zhou X
Med Sci Monit; 2020 Jun; 26():e922836. PubMed ID: 32511216
[TBL] [Abstract][Full Text] [Related]
17. A Differential Transcriptional Regulome Approach to Unpack Cancer Biology: Insights on Renal Cell Carcinoma Subtypes.
Caliskan A; Arga KY
OMICS; 2023 Nov; 27(11):536-545. PubMed ID: 37943533
[TBL] [Abstract][Full Text] [Related]
18. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R; Bottaro DP; Choueiri TK; Gibbs RA; Godwin AK; Haake S; Hakimi AA; Henske EP; Hsieh JJ; Ho TH; Kanchi RS; Krishnan B; Kwiatkowski DJ; Liu W; Merino MJ; Mills GB; Myers J; Nickerson ML; Reuter VE; Schmidt LS; Shelley CS; Shen H; Shuch B; Signoretti S; Srinivasan R; Tamboli P; Thomas G; Vincent BG; Vocke CD; Wheeler DA; Yang L; Kim WY; Robertson AG; ; Spellman PT; Rathmell WK; Linehan WM
Cell Rep; 2018 Apr; 23(1):313-326.e5. PubMed ID: 29617669
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs Associated with Von Hippel-Lindau Pathway in Renal Cell Carcinoma: A Comprehensive Review.
Schanza LM; Seles M; Stotz M; Fosselteder J; Hutterer GC; Pichler M; Stiegelbauer V
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165391
[TBL] [Abstract][Full Text] [Related]
20. A pan-kidney cancer study identifies subtype specific perturbations on pathways with potential drivers in renal cell carcinoma.
Zhan X; Liu Y; Yu CY; Wang TF; Zhang J; Ni D; Huang K
BMC Med Genomics; 2020 Dec; 13(Suppl 11):190. PubMed ID: 33371886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
